Carasent - Share Issue/Capital Change 2024

Carasent ASA - Completion of employee share purchase program

Participants in the Employee Investment Matching Program in March 2022 was

entitled to receive matching shares after two years given that the

participants are still employed with the Group. Please refer to note 18 in the

annual report 2023 for further details.

The program is now completed and the matching shares have vested. The Board of

Carasent has decided to use the right to settle the matching shares in cash.

The cash settlement will be NOK 889,089 based on the closing share price at 14

March 2024.

The following primary insiders of Carasent had outstanding matching shares:

Svein Martin Bjørnstad, CFO: 1,540 shares

Niclas Hugosson, CPO: 1,540 shares

Ingvild Skarestad, Country Manager: 4,621 shares

Björn Jacobsson, CEO Medrave: 4,313 shares

For further details please contact:

Daniel Öhman, CEO Tel: +46 70-855 37 07, or

Svein Martin Bjørnstad, CFO Tel: +47 979 69 493

This information is subject to disclosure under the Norwegian Securities

Trading Act, §5-12. The information was submitted for publication at

2024-03-25 18:13 CET.

AI assistant